CTKB Stock Analysis: Buy, Sell, or Hold?
CTKB - Cytek Biosciences, Inc. Common Stock
$4.62
0.00 (0.00%)
▲
5d:
+0.0%
30d:
+14.07%
90d:
+1.99%
BUY
MODERATE Confidence
Analysis Updated: Jul 10, 2026 12:00 AM ET
Earnings: Aug 05, 2026
22d
Get Alerted When CTKB Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: CTKB shows positive signals but monitor for confirmation. Market pricing in 26.2% decline. Moderate conviction.
💡 BUY OPPORTUNITY: CTKB shows positive signals but monitor for confirmation. Market pricing in 26.2% decline. Moderate conviction.
In-depth Analysis How we analyze
Valuation Analysis: CTKB is currently trading at $4.62, which is considered extended relative to its 30-day fair value range of $4.00 to $4.53. From a valuation perspective, the stock is trading at a discount (Forward PE: 24.3) compared to its historical average (60.5). Remarkably, the market is currently pricing in an annual earnings decline of 26.2% over the next few years. This pessimistic expectation contrasts with the company's recent 73.5% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, CTKB is showing sideways momentum. The price is approaching resistance at $4.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CTKB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.69 (+23.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CTKB is showing sideways momentum. The price is approaching resistance at $4.74. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation.
Market Sentiment: CTKB has a strong technical setup (75/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $5.69 (+23.1%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
EXTENDED
Historical Trading Range
$4.00 -
$4.53
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
61.9%
All Signals
- BEARISH: Price extended above range
- BULLISH: Strong technical setup (75/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 23.1% below Wall St target ($5.69)
Trading Range Analysis
30-Day Trading Range
$4.00 -
$4.53
Current vs Trading Range
EXTENDED
Support & Resistance Levels
Support Level
$4.26
Resistance Level
$4.74
Current Trend
Sideways
Technical data as of
Jul 10, 2026
Fundamental Context
Forward P/E (Next Year Est.)
24.32
Wall Street Target
$5.69
(+23.1%)
Revenue Growth (YoY)
6.5%
Earnings Growth (YoY)
73.5%
Profit Margin
-36.2%
Valuation Discount vs History
-26.2% cheaper
PE vs Historical
24.3 vs 60.5
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-26.2%
(market-implied from PE analysis)
1-Year Target
$4.16
(-10%)
2-Year Target
$3.74
(-19%)
3-Year Target
$3.37
(-27%)
3-Yr Target (if PE normalizes)
(PE: 24→61)
$8.38
(+81%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 24.3 to 60.5
Stabilization Target:
$11.50
(+148.8%)
PE Expansion Potential:
+148.8%
Share & Embed Analysis
Last updated: July 13, 2026 11:15 AM ET
Data refreshes hourly during market hours. Next update: 12:15 PM
Data refreshes hourly during market hours. Next update: 12:15 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CTKB showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 58 HOLD |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
ABT
Abbott Laboratories |
STRONG BUY
27 analysts |
$116 | 63 BUY |
|
MDT
Medtronic PLC |
BUY
32 analysts |
$97 | 66 BUY |
